Dexcom, Inc. (NASDAQ: DXCM), a global leader in glucose biosensing, applauds the Québec government for its recent decision to ...

New RAMQ coverage means eligible Québec residents with type 2 diabetes on intensive insulin therapy can now access Dexcom Continuous Glucose Monitoring (CGM) to simplify diabetes management. Quebec ...

New RAMQ coverage means eligible Québec residents with type 2 diabetes on intensive insulin therapy can now access Dexcom Continuous Glucose Monitoring (CGM) to simplify diabetes management. Dexcom, ...

Teva Canada welcomes the recent announcement from Québec's Ministry of Health regarding changes to the reimbursement ...

The MarketWatch News Department was not involved in the creation of this content.-- Rezurock(R) (belumosudil tablets) now listed for public reimbursement, offering access to adult ...

"If I don’t have the revenue to pay my staff, we’ll close. I don’t mean this as a threat. I mean it as a business reality." ...

Sanofi is pleased to announce that Quebec has added Rezurock® (belumosudil tablets) to the list of medications covered by the Régie de l'assurance maladie du Québec (RAMQ) for adult and pediatric ...

Regeneron Canada Company announced today that Libtayo® (cemiplimab for injection) is now reimbursed by public drug programs in Ontario, British Columbia, Saskatchewan, Nova Scotia, Newfoundland and ...

The federations representing Quebec's medical specialists and family doctors say they will take the government to court to challenge Premier François Legault’s bill, tabled Friday morning, that ...

QUEBEC — Unable to reach a negotiated deal over a new salary structure with doctors, the Coalition Avenir Québec government Friday played hardball, adopting legislation imposing an agreement on them ...